Evidence map›Paper›PMID 40559351›Full record

ArticleMembranes2025

Improving PFAS Rejection by Ultrafiltration Membranes via Polyelectrolyte Multilayer Coating.

Oruc Kaan Turk, Mehmet Cakmakci, Ismail Hakki Zengin, Dogan Karadag, Ebubekir Yuksel

Abstract read
In one paragraph

Article in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oruc Kaan TurkDepartment of Environmental Engineering, Faculty of Civil Engineering, Yıldız Technical University, İstanbul 34220, Türkiye.ORCID 0000-0002-6473-2150
Mehmet CakmakciDepartment of Environmental Engineering, Faculty of Civil Engineering, Yıldız Technical University, İstanbul 34220, Türkiye.ORCID 0000-0003-4784-6006
Ismail Hakki ZenginDepartment of Environmental Engineering, Faculty of Civil Engineering, Yıldız Technical University, İstanbul 34220, Türkiye.ORCID 0009-0009-4138-2467
Dogan KaradagDepartment of Environmental Engineering, Faculty of Civil Engineering, Yıldız Technical University, İstanbul 34220, Türkiye.
Ebubekir YukselDepartment of Environmental Engineering, Faculty of Engineering, Gebze Technical University, Kocaeli 41400, Türkiye.

Funding

Yildiz Technical University Scientific Research Projects 6518
6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFASs), used since the 1940s, are persistent and carcinogenic pollutants. Water is a major exposure route; effective removal is essential. While nanofiltration (NF) and reverse osmosis (RO) are effective but costly, ultrafiltration (UF) membranes offer advantages such as lower cost and higher flux, but their relatively large pore size makes them ineffective for PFAS compounds like perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). Since PFAS removal depends on both pore size and surface properties, this study investigates the effect of polyelectrolyte multilayer coatings using poly(allylamine hydrochloride) (PAH) and poly(acrylic acid) (PAA) on the zeta potential of UF membranes. Pristine UF membranes showed limited performance (UP150: ~2% for both PFOS and PFOA; UP020: 34.4% PFOS, 24.1% PFOA), while coating significantly enhanced removal (coated UP150: 45.3% PFOS, 43.4% PFOA; coated UP020: 77.8% PFOS, 73.3% PFOA). The modified UF membranes achieved PFAS removal efficiencies significantly closer to NF membranes, though still below those of RO (e.g., BW30XLE: up to 91.0% PFOS, 88.3% PFOA; NP030: up to 81.0% PFOS, 79.3% PFOA). Findings emphasize the importance of membrane surface charge and suggest that modified UF membranes offer a promising, low-cost alternative for PFAS removal under low-pressure conditions.

Indexed as

membrane technologyPFASPFOAPFOSzeta potential

Identifiers

PMID40559351
PMCPMC12195447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.